9.63
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Optimizerx Corp Borsa (OPRX) Ultime notizie
XTX Topco Ltd Acquires New Shares in OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat
Connors Investor Services Inc. Has $287,000 Position in OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat
OptimizeRx Releases 2025 Environmental, Social, and Governance (ESG) Report - The Manila Times
Healthcare Tech Leader OptimizeRx Jumps to Elite 1st Decile in ESG Rating: Key 2025 Report Findings - Stock Titan
Geode Capital Management LLC Has $1.95 Million Stock Holdings in OptimizeRx Co. (NASDAQ:OPRX) - Defense World
Walleye Capital LLC Acquires Shares of 138,575 OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat
Press Release Distribution & PR Platform - ACCESS Newswire
OptimizeRx Corp. to Host Conference Call on Q1 2025 Financial Results on May 12, 2025 - Nasdaq
OptimizeRx Sets First Quarter 2025 Conference Call for May 12, 2025, at 4:30 p.m. ET - The Manila Times
Kennedy Capital Management LLC Increases Position in OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat
Analysts Set OptimizeRx Co. (NASDAQ:OPRX) Target Price at $9.06 - MarketBeat
OptimizeRx Corporation Announces Plan for Additional Board of Directors Refreshment - The Manila Times
Whetstone Capital Advisors LLC Invests $6.56 Million in OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat
OptimizeRx Co. (NASDAQ:OPRX) Short Interest Up 22.0% in March - MarketBeat
Is OptimizeRx Corporation (NASDAQ:OPRX) Expensive For A Reason? A Look At Its Intrinsic Value - simplywall.st
Blair William & Co. IL Reduces Stock Position in OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat
OptimizeRx Co. (NASDAQ:OPRX) Sees Significant Increase in Short Interest - Defense World
OptimizeRx Corporation (NASDAQ:OPRX) is favoured by institutional owners who hold 59% of the company - Yahoo Finance
Bank of New York Mellon Corp Has $426,000 Stock Position in OptimizeRx Co. (NASDAQ:OPRX) - Defense World
OptimizeRx Files $75 Million Mixed Shelf - Marketscreener.com
OptimizeRx Corp Files For Mixed Shelf Of Up To $75 MillionSEC Filing - MarketScreener
OptimizeRx Co. (NASDAQ:OPRX) Director James Paul Lang Purchases 321,408 Shares - MarketBeat
Royce & Associates LP Takes Position in OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat
OptimizeRx Corp (NASDAQ: OPRX): The Metrics That Matter Right Now - Stocks Register
OptimizeRx Co. (NASDAQ:OPRX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
OptimizeRx Corp SEC 10-K Report - TradingView
OptimizeRx director James Lang purchases $2.44 million in common stock - Investing.com Australia
OptimizeRx director James Lang purchases $2.44 million in common stock By Investing.com - Investing.com South Africa
OptimizeRx (OPRX) to Release Quarterly Earnings on Wednesday - MarketBeat
Q1 Earnings Forecast for OptimizeRx Issued By B. Riley - MarketBeat
Head to Head Review: OptimizeRx (NASDAQ:OPRX) & CFN Enterprises (OTCMKTS:CNFN) - Defense World
Why OptimizeRx Corp. (OPRX) Soared Last Week? - Insider Monkey
OptimizeRx Corp. (OPRX) Q4 Earnings and Revenues Beat Estimates - MSN
Roth Capital Predicts OptimizeRx's Q1 Earnings (NASDAQ:OPRX) - MarketBeat
Research Analysts Issue Forecasts for OptimizeRx Q1 Earnings - Defense World
OptimizeRx (NASDAQ:OPRX) Releases Earnings Results, Misses Expectations By $0.11 EPS - MarketBeat
OptimizeRx (NASDAQ:OPRX) Upgraded at B. Riley - MarketBeat
OptimizeRx Corp [OPRX] CEO makes an insider purchase of 20,000 shares worth 0.1 million. - Knox Daily
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):